CORLEY CHRISTINA M
Known title: DirectorCIK: 0001270206
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CDW Wins Dell Partner Award, Cited as Undervalued on AI Deal. CDW Corporation was named a Dell Technologies Partner for the fifth straight year, reinforcing its position in the IT distribution sector. Separately, a recent analysis suggests the stock may be undervalued following an AI services deal. The company's trailing P/E of 17.4 remains below the average analyst target of $158.67.
Transaction History
| BXC | ▲ Buy | Option Exercise | 1,297 | — | 5/19/2026 | View on chart |
| CDW | ▲ Buy | Grant | 8 | $0 | 9/10/2024 | View on chart |
| CDW | ▲ Buy | Grant | 7 | $0 | 6/11/2024 | View on chart |
| CDW | ▲ Buy | Grant | 7 | $0 | 3/12/2024 | View on chart |
| CDW | ▲ Buy | Grant | 2,682 | $0 | 3/6/2024 | View on chart |
| CDW | ▲ Buy | Grant | 18,077 | $0 | 2/19/2024 | View on chart |
| CDW | ▼ Sell | Tax Withholding | 8,023 | $1.9M | 2/19/2024 | View on chart |
| CDW | ▲ Buy | Option Exercise | 34,079 | $2.0M | 12/14/2023 | View on chart |
| CDW | ▼ Sell | Open Market | 23,009 | $5.1M | 12/14/2023 | View on chart |
| CDW | ▼ Sell | Open Market | 9,520 | $2.1M | 12/14/2023 | View on chart |
| CDW | ▼ Sell | Open Market | 1,550 | $344K | 12/14/2023 | View on chart |
| CDW | ▲ Buy | Option Exercise | 700 | $41K | 12/13/2023 | View on chart |
| CDW | ▼ Sell | Open Market | 700 | $154K | 12/13/2023 | View on chart |
| CDW | ▲ Buy | Option Exercise | 23,816 | $900K | 11/22/2023 | View on chart |
| CDW | ▲ Buy | Option Exercise | 24,504 | $975K | 11/22/2023 | View on chart |
| CDW | ▼ Sell | Open Market | 19,507 | $4.2M | 11/22/2023 | View on chart |
| CDW | ▼ Sell | Open Market | 15,656 | $3.4M | 11/22/2023 | View on chart |
| CDW | ▼ Sell | Open Market | 13,157 | $2.9M | 11/22/2023 | View on chart |
| CDW | ▼ Sell | Tax Withholding | 10,533 | $2.3M | 2/17/2023 | View on chart |
| CDW | ▲ Buy | Grant | 23,747 | $0 | 2/17/2023 | View on chart |
| CDW | ▲ Buy | Grant | 15,452 | $0 | 2/22/2022 | View on chart |
| CDW | ▼ Sell | Tax Withholding | 6,864 | $1.2M | 2/22/2022 | View on chart |
| CDW | ▲ Buy | Option Exercise | 3,400 | $83K | 12/20/2021 | View on chart |
| CDW | ▼ Sell | Open Market | 3,400 | $635K | 12/20/2021 | View on chart |
| CDW | ▲ Buy | Option Exercise | 3,400 | $83K | 11/18/2021 | View on chart |
| CDW | ▼ Sell | Open Market | 3,400 | $664K | 11/18/2021 | View on chart |
| CDW | ▲ Buy | Option Exercise | 3,400 | $83K | 10/18/2021 | View on chart |
| CDW | ▼ Sell | Open Market | 3,400 | $609K | 10/18/2021 | View on chart |
| CDW | ▲ Buy | Option Exercise | 3,400 | $83K | 9/20/2021 | View on chart |
| CDW | ▼ Sell | Open Market | 3,400 | $638K | 9/20/2021 | View on chart |
| CDW | ▲ Buy | Option Exercise | 3,400 | $83K | 8/18/2021 | View on chart |
| CDW | ▼ Sell | Open Market | 3,400 | $668K | 8/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
BXC: BlueLinx Expands Deal with Westlake Royal Products
BlueLinx announced an expanded partnership with Westlake Royal Building Products, adding exclusive distribution of Kleer® PVC trim and extending market reach for TruExterior® siding and trim. The agreement broadens BlueLinx’s product offerings and could enhance its presence in the building materials market. In a separate note, Citizens Research initiated coverage of BlueLinx with a Market Perform rating.
BXC: BlueLinx Expands Deal with Westlake Royal Products. BlueLinx announced an expanded partnership with Westlake Royal Building Products, adding exclusive distribution of Kleer® PVC trim and extending market reach for TruExterior® siding and trim. The agreement broadens BlueLinx’s product offerings and could enhance its presence in the building materials market. In a separate note, Citizens Research initiated coverage of BlueLinx with a Market Perform rating.